1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc.

CWEB.TO
Charlotte's Web Holdings, Inc.CA flagToronto Stock Exchange
0.45
CAD
+0.01
- -
71.76MMarket Cap
Charlotte's Web Holdings, Inc.
CWEB.TO
(Toronto Stock Exchange)

Recent

price

0.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.16
0.43
0.83
0.98
0.76
0.68
0.51
0.41
0.32
0.32
0.31
Revenue per Share
0.01
0.08
0.14
-0.16
-0.25
-0.98
-0.4
-0.16
-0.19
-0.19
-0.23
Basic EPS, GAAP
-0.01
0.06
-0.08
-0.5
-0.66
-0.24
-0.04
-0.12
-0.16
-0.09
-0.09
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.05
0.13
1.15
1.31
-0.41
-1.34
-1.69
-1.78
-1.92
-2.12
-2.16
Book Value per Share
0.05
0.13
1.44
1.58
1.22
0.91
0.33
0.25
0.08
-0.02
-0.1
Tangible Book Value per Share
93
93
84
97
125
141
147
153
157
157
159
Basic Weighted Avg Shares
15
40
70
95
95
96
74
63
50
50
49
Sales/Revenue/Turnover
6.65
30.05
21.56
-26.22
-53.92
-51.05
-68.32
-63.44
-64.4
-40.62
-39.44
Operating Margin (%)
- -
1
2
4
7
11
9
15
10
6
6
Depreciation Expense
1
7
12
-16
-31
-138
-59
-24
-30
-30
-37
Net Income, GAAP
34.75
36.63
24.03
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
4.17
18.68
16.99
-16.46
-32.22
-143.32
-80
-37.68
-60.09
-59.6
-75.09
Profit Margin (%)
2
8
94
117
115
76
82
55
31
22
19
Working Capital
- -
- -
- -
22
21
20
55
58
57
63
63
LT Debt
5
13
121
154
254
130
78
56
27
-2
-15
Total Equity
- -
74.18
16.68
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
82.32
21.69
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
92.12
21.87
-14
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
49
51
52
LT Finance Leases
13
12
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
159
159
160
Market Capitalization
27
57
114

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
34
30
27
Cash, Cash Equivalents & STI
10
8
5
Accounts Receivable, Net
1
1
1
Inventories
20
18
17
Total Current Liabilities
9
9
8
Payables & Accruals
7
7
7
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-55.27%
-107.53%
Free Cash Flow
- -
17.97%
-41.58%
Net Income, GAAP
- -
51.43%
-0.35%
Sales/Revenue/Turnover
- -
-11.53%
0.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12
12
13
13
50
2025
12
13
12
13
50
2026
11
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.06
-0.07
-0.04
- -
-0.19
2025
-0.04
-0.04
-0.04
- -
-0.19
2026
-0.08
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Eve & Co Incorporated (EEVVF)
Cannabis Suisse Corp. (CSUI)
Landec Corporation (LNDC)
Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
Coenzyme-A Inc. (PPII)
Anbc, Inc. (SYUP)
Business
Charlotte's Web Holdings, Inc. (TSX: CWEB) leads the market in the production and distribution of innovative hemp-derived cannabidiol (CBD) wellness products, including full-spectrum and broad-spectrum hemp extracts containing CBD, CBN, CBC, CBG, THC, terpenes, flavonoids, and other beneficial botanical compounds; its core offerings encompass CBD oil tinctures, gummies for sleep, calming, exercise recovery, immunity, focus, and attention, CBN gummies, hemp-derived THC microdose gummies under the Brightside brand with TiME INFUSION technology for rapid onset, functional mushroom gummies, CBD capsules, topical creams and lotions, and pet products for dogs, marketed under the Charlotte’s Web, CBD CLINIC, CBD MEDIC, and Brightside brands. The Certified B Corporation, founded in 2013 by the Stanley Brothers and headquartered at 700 Tech Court in Louisville, Colorado, operates a vertically integrated model with proprietary U.S. farm-grown hemp genetics, in-house FDA-registered manufacturing, and rigorous third-party testing from soil to shelf; it distributes through direct-to-consumer e-commerce, omnichannel platforms including TikTok Shop, Amazon, Walmart.com, and Faire, retailers, healthcare practitioners, and select distributors across the United States, emphasizing quality, consistency, and science-backed innovation in the botanical wellness sector. Recent developments include the full internalization of Brightside gummy production in 2025 for multi-million-unit capacity and cost savings, expansion of the sleep portfolio to five products across brands with strong traction for CBN Stay Sleep and Knockout THC gummies, entry into nootropics with CBG Focus & Attention Gummies, ongoing growth in functional mushrooms launched late 2024, strategic B2B retail restructuring in Q3 2025 reducing direct sales force amid regulatory shifts for improved profitability and focus on high-margin medical channels, formation of a Scientific Advisory Board led by Chief Scientific Officer Dr. Marcel Bonn-Miller to advance clinical validation and continuing medical education, FDA clearance for Phase 2 trials of DeFloria IND—a collaboration with Ajna BioSciences and British American Tobacco funding—for autism irritability treatment where Charlotte's Web holds exclusive manufacturing rights, and appointment of M. Borgia Walker from BAT to the board effective November 1, 2025, alongside cost optimizations targeting $9 million in annualized savings for 2026 positive cash flow trajectory.